Medtronic Comprehensive Income 2010-2024 | MDT
Medtronic comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Medtronic comprehensive income for the quarter ending October 31, 2024 was $-3.250B, a 3.76% decline year-over-year.
- Medtronic comprehensive income for 2024 was $-3.318B, a 5.17% decline from 2023.
- Medtronic comprehensive income for 2023 was $-3.499B, a 54.48% increase from 2022.
- Medtronic comprehensive income for 2022 was $-2.265B, a 35.01% decline from 2021.
| Medtronic Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-3,318 |
| 2023 | $-3,499 |
| 2022 | $-2,265 |
| 2021 | $-3,485 |
| 2020 | $-3,560 |
| 2019 | $-2,711 |
| 2018 | $-1,786 |
| 2017 | $-2,613 |
| 2016 | $-1,868 |
| 2015 | $-1,184 |
| 2014 | $-597 |
| 2013 | $-492 |
| 2012 | $-473 |
| 2011 | $-224 |
| 2010 | $ |
| 2009 | $ |
| Medtronic Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-10-31 | $-3,250 |
| 2024-07-31 | $-3,410 |
| 2024-04-30 | $-3,318 |
| 2024-01-31 | $-3,459 |
| 2023-10-31 | $-3,377 |
| 2023-07-31 | $-3,674 |
| 2023-04-30 | $-3,499 |
| 2023-01-31 | $-3,189 |
| 2022-10-31 | $-2,361 |
| 2022-07-31 | $-1,939 |
| 2022-04-30 | $-2,265 |
| 2022-01-31 | $-2,879 |
| 2021-10-31 | $-3,042 |
| 2021-07-31 | $-3,209 |
| 2021-04-30 | $-3,485 |
| 2021-01-31 | $-3,922 |
| 2020-10-31 | $-3,843 |
| 2020-07-31 | $-3,782 |
| 2020-04-30 | $-3,560 |
| 2020-01-31 | $-2,546 |
| 2019-10-31 | $-2,611 |
| 2019-07-31 | $-2,484 |
| 2019-04-30 | $-2,711 |
| 2019-01-31 | $-2,458 |
| 2018-10-31 | $-2,612 |
| 2018-07-31 | $-2,323 |
| 2018-04-30 | $-1,786 |
| 2018-01-31 | $-1,382 |
| 2017-10-31 | $-2,060 |
| 2017-07-31 | $-1,924 |
| 2017-04-30 | $-2,613 |
| 2017-01-31 | $-2,879 |
| 2016-10-31 | $-2,328 |
| 2016-07-31 | $-2,024 |
| 2016-04-30 | $-1,868 |
| 2016-01-31 | $-2,965 |
| 2015-10-31 | $-1,471 |
| 2015-07-31 | $-1,356 |
| 2015-04-30 | $-1,184 |
| 2015-01-31 | $-661 |
| 2014-10-31 | $-506 |
| 2014-07-31 | $-488 |
| 2014-04-30 | $-597 |
| 2014-01-31 | $-618 |
| 2013-10-31 | $-567 |
| 2013-07-31 | $-576 |
| 2013-04-30 | $-492 |
| 2013-01-31 | $-472 |
| 2012-10-31 | $-484 |
| 2012-07-31 | $-515 |
| 2012-04-30 | $-473 |
| 2012-01-31 | $-276 |
| 2011-10-31 | $-157 |
| 2011-07-31 | $-85 |
| 2011-04-30 | $-224 |
| 2011-01-31 | $-225 |
| 2010-10-31 | $-397 |
| 2010-07-31 | $-353 |
| 2010-04-30 | |
| 2010-01-31 | $-201 |
| 2009-10-31 | $-253 |
| 2009-07-31 | $-210 |
| 2009-04-30 | |
| 2009-01-31 | $-35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $103.429B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.797B | 24.85 |
| Boston Scientific (BSX) | United States | $139.837B | 40.20 |
| Stryker (SYK) | United States | $139.395B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $110.104B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.664B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.193B | 26.76 |
| GE HealthCare Technologies (GEHC) | United States | $38.725B | 20.09 |
| ResMed (RMD) | United States | $34.324B | 28.21 |
| Terumo (TRUMY) | Japan | $28.025B | 39.58 |
| Koninklijke Philips (PHG) | Netherlands | $24.269B | 18.58 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.811B | 13.25 |
| Insulet (PODD) | United States | $19.068B | 75.93 |
| Baxter (BAX) | United States | $15.022B | 9.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.471B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.568B | 32.52 |
| BellRing Brands (BRBR) | United States | $9.145B | 36.79 |
| Demant (WILYY) | Denmark | $8.596B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.666B | 15.49 |
| Haemonetics (HAE) | United States | $3.851B | 18.79 |
| ICU Medical (ICUI) | United States | $3.779B | 35.98 |
| Prestige Consumer Healthcare (PBH) | United States | $3.656B | 18.18 |
| Perrigo (PRGO) | Ireland | $3.326B | 9.79 |
| Envista Holdings (NVST) | United States | $3.198B | 23.82 |
| QuidelOrtho (QDEL) | United States | $3.077B | 19.81 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| Neogen (NEOG) | United States | $2.678B | 30.90 |
| GN Store Nord (GNNDY) | Denmark | $2.593B | 16.63 |
| LeMaitre Vascular (LMAT) | United States | $2.104B | 51.14 |
| Green Thumb Industries (GTBIF) | United States | $1.564B | 27.37 |
| AtriCure (ATRC) | United States | $1.531B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.364B | 9.75 |
| InMode (INMD) | Israel | $1.335B | 8.03 |
| BioLife Solutions (BLFS) | United States | $1.234B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.225B | 0.00 |
| Owens & Minor (OMI) | United States | $1.071B | 8.37 |
| Curaleaf Holdings (CURLF) | Canada | $0.942B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.812B | 14.32 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.551B | 24.31 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Omeros (OMER) | United States | $0.512B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.423B | 0.00 |
| ZimVie (ZIMV) | United States | $0.372B | 31.37 |
| Valneva SE (VALN) | France | $0.369B | 0.00 |
| Quanterix (QTRX) | United States | $0.363B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.44 |
| Biote (BTMD) | United States | $0.307B | 6.73 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.282B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.270B | 18.10 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.249B | 52.20 |
| Aurora Cannabis (ACB) | Canada | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 3.15 |
| Utah Medical Products (UTMD) | United States | $0.207B | 14.26 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| Brainsway (BWAY) | Israel | $0.177B | 94.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.21 |
| Quipt Home Medical (QIPT) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Veru (VERU) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| INLIF (INLF) | $0.068B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Exagen (XGN) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.30 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |